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There has been a strong interest for controlled release solid
dosage forms, and to achieve controlled release, coating of par-
ticulates is often attempted to modify drug release. Due to the
disadvantages of coated single-unit dosage forms, such as
occurrences of dose dumping and local irritation, coated multi-
particulates are often preferred. However, coated multi-
particulates are often filled into capsules. Compressed tablet
dosage form is more desirable than capsules as the unit pro-
duction costs of tablets are lower and tablet presses are more
common. The avoidance of gelatin is another impetus. Com-
paction of multi-particulates into tablets can also allow dosing
flexibility as tablets may be scored. However, compaction forces
can result in structural damage to coatings, affecting their func-
tion. Hence, it is important to understand the factors that can
affect coat damage during compression, requiring research into
the various aspects of compacting coated multi-particulates,
from the coating process, coat quality, nature of cores, accom-
panying ingredients, tooling type, and process of force
application among others.The structural damage during com-
pression may be reduced by using smaller particles [1], but
coating small particles is challenging [2]. Thus, judicious
selection and optimization of the fluid bed coating process are
important. It is also necessary to examine the impact of com-
pacting coated particles with commonly used excipients, often
necessitate the design of sacrificial granules to mitigate the
harsh conditions required for the formation of compacts in a
die of the tablet press [3,4]. Excipients with smaller mean par-
ticle size could reduce the coat damage of multi-particulates
during compression [5]. However, even with the usage of the
finest grade of lactose, the drug release was about 3 times faster
than the uncompressed coated particles. Besides excipient prop-
erties, the size of the coated particles could have also
contributed to the failure of coat function after compression.
It is also of interest to explore the use of smaller coated par-
ticles for compression. Nevertheless, the coating of small
particles has always been a challenge due to the propensity
of small particles to agglomerate [6].
In order to reduce the amount of agglomeration, the spray
rate of the coating media needed to be reduced. However, re-
ducing spray rate increased the level of spray drying, resulting
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in significant loss of coating material. In addition, coat quality
could be affected when coating is applied in very dry coating
conditions. Thus, understanding and optimizing the coating
process to determine the ideal coating parameters for coating
small particles is very important. Application of a side spray
onto a swirling flow of particulates is very successful for coating
small particles [7], and a high spray rate with minimal ag-
glomeration can be achieved for pellets in the low few hundred
microns size range. Careful application of the compaction force
onto coated multi-particulates could also help to mitigate the
extent of coat damage during the compaction. This can be
achieved by the use of air compensator to limit the applied force
and extend compaction dwell time. This presentation will
examine the various factors involved in the preparation and
compaction of coated multi-particulates, highlighting the
various research studies carried out in this area.
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